
Estela Rodriguez/X
Feb 4, 2025, 16:31
Estela Rodriguez: Discussing emerging therapies in lung cancer at WLC25
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared a post on X:
“Always a pleasure to listen to Gregory Riely from Memorial Sloan Kettering Cancer Center discussing emerging therapies in lung cancer targeting TP53, MTAP deletion, SMARC4 alterations.”
More posts featuring Estela Rodriguez.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 5, 2025, 15:54
Mar 5, 2025, 13:46